Pfizer (NYSE:PFE) Sells Ireland Real Estate

Pfizer (NYSE:PFE) has reportedly decided to sell a manufacturing facility in Ireland. Pfizer (NYSE:PFE) Sells Ireland Real Estate Reports say that a 37,000 square-meter facility in Dun Laoghaire near Dublin will be acquired by Amgen in the second quarter of this year. The facility is currently owned by Pfizer (NYSE:PFE). Paul Duffy, VP of primary care at Pfizer (NYSE:PFE) Global Supply said, "This is a good day for colleagues and for Ireland Inc. as it proves we remain an attractive location for high calibre investment." Pfizer Inc. (NYSE:PFE) stocks were at 19.81 at the end of the last day’s trading. There’s been a 15.2% change in the stock price over the past 3 months. Pfizer Inc. (NYSE:PFE) Analyst Advice Consensus Opinion: Moderate Buy Mean recommendation: 1.52 (1=Strong Buy, 5=Strong Sell) 3 Months Ago: 1.58 Zack’s Rank: 2 out of 15 in the industry
Negocioenlinea
tdp2664
E money daily